The NOTCH3 enhancer generated by NRF2 in cooperation with CEBPB establishes the NRF2-NOTCH3 axis and drives malignancy of NRF2-activated NSCLCs by promoting tumor-initiating activity. Here, CEBPB is linked to neoplasm.